Who owns Kymera?
Palladium Equity Partners Acquires Kymera International from Platinum Equity. Who are Kymera International’s investors? Edmond de Rothschild Private Equity and Palladium Equity Partners have invested in Kymera International.
What is the annual sales of Kymera?
The revenue of Kymera Therapeutics with headquarters in the United States amounted to 78. U. S. The current market capitalization of Kymera Therapeutics is $1. B.Total Valuation KYMR has a market cap or net worth of $2. The enterprise value is $1.